Close

Pre-Open Stock Movers 05/07: (IBIO) (BILL) (AXON) Higher; (CCIX) (APPN) (FROG) Lower (more...)

May 7, 2021 9:20 AM EDT

Pre-Open Stock Movers

ChemoCentryx, Inc., (Nasdaq: CCXI) 55.8% LOWER; mixed vote from FDA Arthritis Advisory Committee on avacopan for the treatment of Antineutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (or AAV). Multiple analyst downgrades.

iBio, Inc. (NYSE: IBIO) 43% HIGHER; provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.

Bill.com (NYSE: BILL) 15% HIGHER; reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $54.6 million. Entered into a definitive agreement to acquire Divvy in a stock and cash transaction valued at approximately $2.5 billion.

Appian Corporation (NASDAQ: APPN) 14% LOWER; reported Q1 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $88.9 million versus the consensus estimate of $82.67 million. Appian Corporation sees Q2 2021 EPS of ($0.26)-($0.23), versus the consensus of ($0.16). Appian Corporation sees Q2 2021 revenue of $77-78 million, versus the consensus of $84.05 million. Appian Corporation sees FY2021 EPS of ($0.68)-($0.65), versus the consensus of ($0.59). Appian Corporation sees FY2021 revenue of $353-355 million, versus the consensus of $355.44 million.

Axon (NASDAQ: AXON) 13% HIGHER; reported Q1 EPS of $0.31, $0.10 better than the analyst estimate of $0.21. Revenue for the quarter came in at $195 million versus the consensus estimate of $165.89 million. Axon sees Q2 2021 revenue of $780-820 million, versus the consensus of $760.61 million.

T2 Biosystems, Inc. (NASDAQ: TTOO) 12% HIGHER; announced today that the Company has modified the terms of its existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to accelerate the development of multiple products that are being funded under the contract.

Stamps.com (NASDAQ: STMP) 10% LOWER; reported Q1 EPS of $2.08, $0.39 better than the analyst estimate of $1.69. Revenue for the quarter came in at $189.1 million versus the consensus estimate of $188.19 million.

JFrog Ltd. (NASDAQ: FROG) 9.6% LOWER; reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $44.82 million. JFrog Ltd. sees Q2 2021 EPS of $0.00-$0.01, versus the consensus of $0.01. JFrog Ltd. sees Q2 2021 revenue of $47.6-48.6 million, versus the consensus of $48.12 million. JFrog Ltd. sees FY2021 revenue of $198-204 million, versus the consensus of $201.26 million.

Shake Shack (NYSE: SHAK) 8.6% LOWER; reported Q1 EPS of $0.04, $0.13 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $155.3 million versus the consensus estimate of $161.9 million.

Roku (NASDAQ: ROKU) 8.2% HIGHER; reported Q1 EPS of $0.54, $0.67 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $574.2 million versus the consensus estimate of $490.56 million. Roku sees Q2 2021 revenue of $615 million, versus the consensus of $549.4 million.

Tilray (NASDAQ: TLRY) 8% HIGHER; Jefferies upgraded from Underperform to Buy with a price target of $23.

Datadog, Inc. (NASDAQ: DDOG) 7.5% HIGHER; reported Q1 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $198.5 million versus the consensus estimate of $186.71 million. Datadog, Inc. sees Q2 2021 EPS of $0.03-$0.04, versus the consensus of $0.03. Datadog, Inc. sees Q2 2021 revenue of $211-213 million, versus the consensus of $195.51 million. Datadog, Inc. sees FY2021 EPS of $0.13-$0.16, versus the consensus of $0.14. Datadog, Inc. sees FY2021 revenue of $880-890 million, versus the consensus of $833.65 million.

So-Young International Inc. (NASDAQ: SY) 7% HIGHER; Refutes Blue Orca Capital’s Report and Announces $70 Million Share Repurchase Program

Cloudflare (NYSE: NET) 6.9% HIGHER; reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $138.1 million versus the consensus estimate of $131.02 million. Cloudflare sees Q2 2021 EPS of ($0.04)-($0.03), versus the consensus of ($0.03). Cloudflare sees Q2 2021 revenue of $145.5-146.5 million, versus the consensus of $139.1 million. Cloudflare sees FY2021 EPS of ($0.11)-($0.10), versus the consensus of ($0.09). Cloudflare sees FY2021 revenue of $612-616 million, versus the consensus of $593 million.

Groupon (NASDAQ: GRPN) 6.7% HIGHER; reported Q1 EPS of $0.25, $0.83 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $263.8 million versus the consensus estimate of $225 million. Groupon sees FY2021 revenue of $950-990 million, versus the consensus of $966.3 million.

Beyond Meat (NASDAQ: BYND) 6.5% LOWER; reported Q1 EPS of ($0.42), $0.23 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $108.2 million versus the consensus estimate of $113.67 million. Beyond Meat sees Q2 2021 revenue of $135-150 million, versus the consensus of $142.8 million.

Sprouts Farmers Market (NASDAQ: SFM) 5.2% LOWER; reported Q1 EPS of $0.70, $0.10 better than the analyst estimate of $0.60. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.63 billion. Sprouts Farmers Market sees FY2021 EPS of $1.87-$2.00 vs consensus of $1.87.

Monster Beverage (NASDAQ: MNST) 5% LOWER; reported Q1 EPS of $0.59, $0.02 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.22 billion.

Peloton (NASDAQ: PTON) 4% HIGHER; reported Q3 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.11 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Jefferies & Co, Stock Buyback, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, Pre Market Movers, AdCom, FDA